Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases.
Leukemia
; 34(6): 1487-1494, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-156619
ABSTRACT
Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse outcome of SARS-CoV-2 infection, and therefore, guidance regarding prevention and management of the infection as well as safe administration of cancer-therapy is required. Here, we provide recommendations for the management of patients with malignant disease in the times of COVID-19. These recommendations were prepared by an international panel of experts and then consented by the EHA Scientific Working Group on Infection in Hematology. The primary aim is to enable clinicians to provide optimal cancer care as safely as possible, since the most important protection for patients with malignant disease is the best-possible control of the underlying disease.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Infection Control
/
Practice Guidelines as Topic
/
Infectious Disease Transmission, Patient-to-Professional
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
/
Patient Care
/
Neoplasms
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Leukemia
Journal subject:
Hematology
/
Neoplasms
Year:
2020
Document Type:
Article
Affiliation country:
S41375-020-0832-y
Similar
MEDLINE
...
LILACS
LIS